JP2011515470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515470A5 JP2011515470A5 JP2011501820A JP2011501820A JP2011515470A5 JP 2011515470 A5 JP2011515470 A5 JP 2011515470A5 JP 2011501820 A JP2011501820 A JP 2011501820A JP 2011501820 A JP2011501820 A JP 2011501820A JP 2011515470 A5 JP2011515470 A5 JP 2011515470A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- cord blood
- isolated
- administered
- population according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 44
- 210000004700 fetal blood Anatomy 0.000 claims 21
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 8
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 8
- 208000006011 Stroke Diseases 0.000 claims 7
- 210000005013 brain tissue Anatomy 0.000 claims 4
- 230000000451 tissue damage Effects 0.000 claims 4
- 231100000827 tissue damage Toxicity 0.000 claims 4
- 230000001684 chronic effect Effects 0.000 claims 3
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 2
- 210000005087 mononuclear cell Anatomy 0.000 claims 2
- 230000009529 traumatic brain injury Effects 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000002804 pyramidal tract Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7217308P | 2008-03-28 | 2008-03-28 | |
| US61/072,173 | 2008-03-28 | ||
| PCT/US2009/001915 WO2009120368A2 (en) | 2008-03-28 | 2009-03-26 | Treatment of brain damage using umbilical cord blood cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014148317A Division JP6138090B2 (ja) | 2008-03-28 | 2014-07-18 | 臍帯血細胞を用いた脳損傷の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011515470A JP2011515470A (ja) | 2011-05-19 |
| JP2011515470A5 true JP2011515470A5 (OSRAM) | 2013-05-23 |
Family
ID=41114539
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011501820A Pending JP2011515470A (ja) | 2008-03-28 | 2009-03-26 | 臍帯血細胞を用いた脳損傷の処置 |
| JP2014148317A Expired - Fee Related JP6138090B2 (ja) | 2008-03-28 | 2014-07-18 | 臍帯血細胞を用いた脳損傷の処置 |
| JP2016162002A Expired - Fee Related JP6401757B2 (ja) | 2008-03-28 | 2016-08-22 | 臍帯血細胞を用いた脳損傷の処置 |
| JP2018094486A Expired - Fee Related JP6655123B2 (ja) | 2008-03-28 | 2018-05-16 | 臍帯血細胞を用いた脳損傷の処置 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014148317A Expired - Fee Related JP6138090B2 (ja) | 2008-03-28 | 2014-07-18 | 臍帯血細胞を用いた脳損傷の処置 |
| JP2016162002A Expired - Fee Related JP6401757B2 (ja) | 2008-03-28 | 2016-08-22 | 臍帯血細胞を用いた脳損傷の処置 |
| JP2018094486A Expired - Fee Related JP6655123B2 (ja) | 2008-03-28 | 2018-05-16 | 臍帯血細胞を用いた脳損傷の処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11318170B2 (OSRAM) |
| EP (1) | EP2282748B1 (OSRAM) |
| JP (4) | JP2011515470A (OSRAM) |
| CN (1) | CN102036671A (OSRAM) |
| AU (1) | AU2009229153B2 (OSRAM) |
| CA (1) | CA2719740C (OSRAM) |
| IL (1) | IL208406A0 (OSRAM) |
| SG (1) | SG191701A1 (OSRAM) |
| TW (2) | TW201636033A (OSRAM) |
| WO (1) | WO2009120368A2 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9694038B2 (en) * | 2000-04-06 | 2017-07-04 | Wayne P. Franco | Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| BR112014014560A8 (pt) * | 2011-12-14 | 2017-07-04 | Yeda Res & Dev | subpopulação de monócitos humanos para tratamento de lesões do sistema nervoso central |
| CN103599129A (zh) * | 2013-11-07 | 2014-02-26 | 唐明淇 | 一种人干细胞组合物在制备用于治疗阿尔茨海默症的药物中的用途 |
| JPWO2015174087A1 (ja) * | 2014-05-16 | 2017-04-20 | 公益財団法人先端医療振興財団 | 脳梗塞の予防及び／又は治療の為の医薬 |
| JP7126703B2 (ja) * | 2016-05-24 | 2022-08-29 | 国立大学法人 東京大学 | 臍帯由来細胞を含む脳障害の治療剤 |
| CN108269615A (zh) * | 2018-03-14 | 2018-07-10 | 南宁市第人民医院 | 一种脐血pH值与婴幼儿脑损伤的关系评价方法 |
| TW202120108A (zh) * | 2019-08-20 | 2021-06-01 | 美商永生生技股份有限公司 | 心血管疾病之治療 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965204A (en) | 1984-02-06 | 1990-10-23 | The Johns Hopkins University | Human stem cells and monoclonal antibodies |
| US4714680B1 (en) | 1984-02-06 | 1995-06-27 | Univ Johns Hopkins | Human stem cells |
| US5087570A (en) | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| IL151650A0 (en) | 2000-03-09 | 2003-04-10 | Saneron Ccel Therapeutics Inc | Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| WO2001075094A1 (en) * | 2000-04-04 | 2001-10-11 | Thomas Jefferson University | Application of myeloid-origin cells to the nervous system |
| US8062837B2 (en) | 2002-02-14 | 2011-11-22 | Stemcyte, Inc. | Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making |
| US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
| DE10330216A1 (de) * | 2003-07-03 | 2005-01-20 | Jensen, Arne Wilhelm Oluf, Prof. Dr. | Verwendung von Stammzellen aus Nabelschnurblut zur Verhinderung von Hirnschäden infolge Sauerstoffmangel und zur Neuroprotektion |
| WO2005112959A2 (en) * | 2004-05-17 | 2005-12-01 | Regents Of The University Of Minnesota | Use of umbilical cord blood stem cells to treat ischemic event |
| US20060264365A1 (en) | 2005-05-18 | 2006-11-23 | Hung Li | Treatment of brain tissue damage |
| US7569545B2 (en) | 2005-05-20 | 2009-08-04 | Academia Sinica | Methods of increasing neurotrophic factor expression |
| JP5925408B2 (ja) | 2005-09-23 | 2016-05-25 | タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルＴｉｇｅｎｉｘ Ｓ．Ａ．Ｕ． | 免疫調節活性を有する細胞集団、単離方法および使用 |
| US7427597B2 (en) | 2005-11-21 | 2008-09-23 | Academia Sinica | Method of treating brain tissue damages |
| US8329166B2 (en) | 2005-12-16 | 2012-12-11 | Academia Sinica | Pluripotent olfactory stem cells |
| EP2432481A2 (en) | 2009-05-21 | 2012-03-28 | Stemcyte Inc. | Cell therapy for brain tissue damage |
-
2009
- 2009-03-26 EP EP09725197.9A patent/EP2282748B1/en not_active Not-in-force
- 2009-03-26 JP JP2011501820A patent/JP2011515470A/ja active Pending
- 2009-03-26 AU AU2009229153A patent/AU2009229153B2/en not_active Ceased
- 2009-03-26 US US12/935,077 patent/US11318170B2/en active Active
- 2009-03-26 CN CN2009801155168A patent/CN102036671A/zh active Pending
- 2009-03-26 WO PCT/US2009/001915 patent/WO2009120368A2/en not_active Ceased
- 2009-03-26 CA CA2719740A patent/CA2719740C/en not_active Expired - Fee Related
- 2009-03-26 SG SG2013050984A patent/SG191701A1/en unknown
- 2009-03-27 TW TW105122319A patent/TW201636033A/zh unknown
- 2009-03-27 TW TW098110103A patent/TWI593417B/zh not_active IP Right Cessation
-
2010
- 2010-10-03 IL IL208406A patent/IL208406A0/en unknown
-
2014
- 2014-07-18 JP JP2014148317A patent/JP6138090B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-22 JP JP2016162002A patent/JP6401757B2/ja not_active Expired - Fee Related
-
2018
- 2018-05-16 JP JP2018094486A patent/JP6655123B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011515470A5 (OSRAM) | ||
| EP4410976A3 (en) | Methods of using zscan4 for rejuvenating human cells | |
| SG10201901922VA (en) | Compositions and methods for treating metabolic disorders | |
| EP3663366A3 (de) | Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe | |
| NZ617412A (en) | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells | |
| WO2015092020A3 (en) | Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine | |
| EP3406260A3 (en) | Cyclin dependent kinase inhibitors and methods of use | |
| WO2014175917A8 (en) | Multiparticulate l-menthol formulations and related methods | |
| EP2793993A4 (en) | RECOVERY AND PROCESSING OF HUMAN IN VIVO EMBRYOS | |
| EA201490796A1 (ru) | Дофамининовые (да) нейроны среднего мозга для трансплантации | |
| MY162984A (en) | Humanized m-csf mice | |
| WO2012174338A3 (en) | Method of selecting therapeutic indications | |
| ES2572211T3 (es) | Regeneración de músculo esquelético utilizando células madre mesenquimales | |
| EP3587558A3 (en) | Methods of populating a gastrointestinal tract | |
| WO2012018446A3 (en) | Anchor delivery system | |
| WO2016105984A3 (en) | Tissue-based compositions and methods of use thereof | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| EP3257943A3 (en) | Methods and vectors for cell immortalisation | |
| BR112014003704A2 (pt) | moduladores ror gama | |
| EP4461326A3 (en) | Flexible system for delivering an anchor | |
| EP2729148A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON | |
| GB201111485D0 (en) | Drug composition and its use in therapy | |
| WO2014106116A3 (en) | Therapeutic compositions comprising antibodies | |
| WO2014058979A3 (en) | Laquinimod for reducing thalamic damage in multiple sclerosis | |
| EP2478901A3 (en) | Neurogenic compounds |